Filing Details
- Accession Number:
- 0001209191-17-050305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-25 17:33:43
- Reporting Period:
- 2017-08-23
- Accepted Time:
- 2017-08-25 16:33:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Biotime Inc | BTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1308105 | Russell Skibsted | 1010 Atlantic Avenue, Suite 102 Alameda CA 94501 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Acquisiton | 2017-08-23 | 2,000 | $2.64 | 2,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchase price per share represents a weighted average of prices ranging from $2.6373 to $2.6475 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- Does not include shares that may be acquired upon the exercise of certain stock options.
Billionaire Hedge Funds
